BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CS08399 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of CS08399\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07583771-2442@assetmemo.bio
DTSTAMP:20261121T005405Z
DTSTART;VALUE=DATE:20290831
DTEND;VALUE=DATE:20290901
SUMMARY:CS08399: Phase 1 readout est. (NCT07583771)
DESCRIPTION:CS08399\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Phase
  Ⅰ Study of CS08399 in Participants With MTAP-deleted Solid Tumors and L
 ymphoma\nEstimated primary completion: August 2029. This is a ClinicalTria
 ls.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pa
 ge: https://assetmemo.bio/drug/cs08399#upcoming-events\nRegistry record: h
 ttps://clinicaltrials.gov/study/NCT07583771
URL:https://assetmemo.bio/drug/cs08399#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
